Circulation: Cardiovascular Genetics

Journal

Publication Venue For

  • One Size Does Not Fit All: Genetic Prediction of Kawasaki Disease Treatment Response in Diverse Populations.  10. 2017
  • PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data from 9 Studies of Blacks and Whites.  10. 2017
  • Admixture Mapping of Subclinical Atherosclerosis and Subsequent Clinical Events among African Americans in 2 Large Cohort Studies.  10. 2017
  • Epigenetic Patterns in Blood Associated with Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results from Genome-Wide Association Studies.  10. 2017
  • Epigenetic Signatures of Cigarette Smoking.  9:436-447. 2016
  • Spectrum and prevalence of CALM1-, CALM2-, and CALM3-encoded calmodulin variants in long QT syndrome and functional characterization of a novel long QT syndrome-associated calmodulin missense variant, E141G.  9:136-146. 2016
  • Top advances in functional genomics and translational biology for 2015.  9:189-192. 2016
  • Endothelial Cell Bioenergetics and Mitochondrial DNA Damage Differ in Humans Having African or West Eurasian Maternal Ancestry.  9:26-36. 2016
  • Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD..  9:71-78. 2016
  • Association of a 62 Variants Type 2 Diabetes Genetic Risk Score with Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter Study.  8:507-515. 2015
  • Multiethnic Genome-Wide Association Study of Cerebral White Matter Hyperintensities on MRI.  8:398-409. 2015
  • Long noncoding Mhrt RNA: Molecular crowbar unravel insights into heart failure treatment.  8:213-215. 2015
  • Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels.  7:830-837. 2014
  • Long noncoding RNA-MicroRNA-mRNA a novel tripartite axis in the regulation of cardiac hypertrophy.  7:729-731. 2014
  • MicroRNA passenger strand orchestral symphony of paracrine signaling.  7:567-568. 2014
  • Obesity genetics and epigenetics: Dissecting causality.  7:395-396. 2014
  • Metabolomics yield a novel biomarker for predicting diabetes mellitus risk in humans.  7:95-96. 2014
  • Top advances in functional genomics and translational biology for 2013.  7:89-92. 2014
  • Salt, immune function, and the risk of autoimmune diseases.  6:642-643. 2013
  • Glucagon-like peptide-1 receptor-atrial natriuretic peptide axis: A novel mechanism for blood pressure regulation.  6:523. 2013
  • Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study..  6:391-399. 2013
  • Establishing validity of pharmacogenomic findings: From replication to triangulation.  6:409-412. 2013
  • Response to John P.A. Ioannidis, MD, DSc.  6:418. 2013
  • Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus.  6:97-105. 2013
  • Role of activating FcγR gene polymorphisms in kawasaki disease susceptibility and intravenous immunoglobulin response.  5:309-316. 2012
  • Response to letter regarding article, "Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the GOLDN study".  4. 2011
  • Apolipoprotein e polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the genetics of lipid lowering and diet network (GOLDN) study.  3:462-467. 2010

    • International Standard Serial Number (issn)

  • 1942-325X

    • Electronic International Standard Serial Number (eissn)

  • 1942-3268